Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cystic macular oedema on spectral-domain optical coherence tomography in choroideremia patients without cystic changes on fundus examination.

Autor: Genead, M. A.¹, Fishman, G. A.¹ gerafish@uic.edu

Publikováno v: Eye. Jan2011, Vol. 25 Issue 1, p84-90. 7p.

Infantile Nystagmus Syndrome—Associated Inherited Retinal Diseases: Perspectives from Gene Therapy Clinical Trials.

Autor: Gong, Xiaoming^1,2 (AUTHOR) rhertle@akronchildrens.org, Hertle, Richard W.^1,2 (AUTHOR)

Publikováno v: Life (2075-1729). Nov2024, Vol. 14 Issue 11, p1356. 25p.

Evaluation of Retinal Structure and Visual Function in Blue Cone Monochromacy to Develop Clinical Endpoints for L-opsin Gene Therapy.

Autor: Cideciyan, Artur V.¹ (AUTHOR) aroman@pennmedicine.upenn.edu, Roman, Alejandro J.¹ (AUTHOR) raymond.warner@pennmedicine.upenn.edu, Warner, Raymond L.¹ (AUTHOR) asumarok@pennmedicine.upenn.edu, Sumaroka, Alexander¹ (AUTHOR) vivian.wu@pennmedicine.upenn.edu, Wu, Vivian¹ (AUTHOR) yuyou.jiang@pennmedicine.upenn.edu, Jiang, Yu Y.¹ (AUTHOR) mswider@pennmedicine.upenn.edu, Swider, Malgorzata¹ (AUTHOR) garafalo@pennmedicine.upenn.edu, Garafalo, Alexandra V.¹ (AUTHOR) iryna.viarbitskaya@pennmedicine.upenn.edu, Viarbitskaya, Iryna¹ (AUTHOR) robert.russell2@pennmedicine.upenn.edu, Russell, Robert C.¹ (AUTHOR) jwmorgan@pennmedicine.upenn.edu, Kohl, Susanne² (AUTHOR) susanne.kohl@med.uni-tuebingen.de, Wissinger, Bernd² (AUTHOR) bernd.wissinger@med.uni-tuebingen.de, Ripamonti, Caterina³ (AUTHOR) c.ripamonti@crsltd.com, Barbur, John L.⁴ (AUTHOR) j.l.barbur@city.ac.uk, Bach, Michael⁵ (AUTHOR) bach@uni-freiburg.de, Carroll, Joseph⁶ (AUTHOR) jcarroll@mcw.edu, Morgan, Jessica I. W.¹ (AUTHOR) aleman@pennmedicine.upenn.edu, Aleman, Tomas S.¹ (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10639. 23p.

Comprehensive Ocular and Systemic Safety Evaluation of Polysialic Acid-Decorated Immune Modulating Therapeutic Nanoparticles (PolySia-NPs) to Support Entry into First-in-Human Clinical Trials.

Autor: Krishnan, Anitha¹ (AUTHOR) akrishnan@avicedarx.com, Callanan, David G.¹ (AUTHOR) dcallanan@avicedarx.com, Sendra, Victor G.¹ (AUTHOR) alad@avicedarx.com, Lad, Amit¹ (AUTHOR) schristian@avicedarx.com, Christian, Sunny¹ (AUTHOR) rearla@avicedarx.com, Earla, Ravinder¹ (AUTHOR) akhanehzar@avicedarx.com, Khanehzar, Ali¹ (AUTHOR) mgreene@avicedarx.com, Tolentino, Andrew J.² (AUTHOR) atolent@berkeley.edu, Vailoces, Valory Anne Sarmiento³ (AUTHOR) valory_vailoces@gwu.edu, Greene, Michelle K.^1,4 (AUTHOR) cscott@avicedarx.com, Scott, Christopher J.^1,4 (AUTHOR) dkunimoto@avicedarx.com, Kunimoto, Derek Y.¹ (AUTHOR) thassan@avicedarx.com, Hassan, Tarek S.^1,5 (AUTHOR) mgenead@avicedarx.com, Genead, Mohamed A.¹ (AUTHOR), Tolentino, Michael J.^1,6,7 (AUTHOR) vsendra@avicedarx.com

Publikováno v: Pharmaceuticals (14248247). Apr2024, Vol. 17 Issue 4, p481. 21p.